Protein Summary
Transcriptional corepressor which facilitates transcriptional repression via its association with DNA-binding transcription factors and recruitment of other corepressors and histone-modifying enzymes (PubMed:12559562, PubMed:15203199). Can repress the expression of MMP7 in a ZBTB33-dependent manner (PubMed:23251453). Can repress transactivation mediated by TCF12 (PubMed:16803958). Acts as a negative regulator of adipogenesis (By similarity). The AML1-MTG8/ETO fusion protein frequently found in leukemic cells is involved in leukemogenesis and contributes to hematopoietic stem/progenitor cell self-renewal (PubMed:23812588). This gene encodes a member of the myeloid translocation gene family which interact with DNA-bound transcription factors and recruit a range of corepressors to facilitate transcriptional repression. The t(8;21)(q22;q22) translocation is one of the most frequent karyotypic abnormalities in acute myeloid leukemia. The translocation produces a chimeric gene made up of the ...more
- ENST00000265814
- ENSP00000265814
- ENSG00000079102
- ENST00000360348
- ENSP00000353504
- ENST00000396218
- ENSP00000379520
- ENST00000422361
- ENSP00000390137
- ENST00000518844
- ENSP00000430728
- ENST00000520724
- ENSP00000428742
- ENST00000523629
- ENSP00000428543
- ENST00000613302
- ENSP00000481799
- ENST00000613886
- ENSP00000478331
- ENST00000614812
- ENSP00000481315
- ENST00000617740
- ENSP00000481112
- AML1T1
- CBFA2T1
- CDR
- ETO
- MTG8
- ZMYND2
- CDR
- ETO
- MTG8
- AML1T1
- ZMYND2
- CBFA2T1
- AML1-MTG8
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
PubMedID | 0.91 | ||
transcription factor | 0.84 | ||
biological term | 0.83 | ||
kinase perturbation | 0.76 | ||
disease perturbation | 0.74 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 428.85 (req: < 5)
Gene RIFs: 137 (req: <= 3)
Antibodies: 256 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 428.85 (req: >= 5)
Gene RIFs: 137 (req: > 3)
Antibodies: 256 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 7
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0